IMA Advisory Services’s Biogen BIIB Stock Holding History

IMA Advisory Services’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.18K	Buy	24 +15	+167%	+$2.87K	﹤0.01%	900
2026 Q1	$1.65K	Buy	+9	New	+$1.66K	﹤0.01%	692
2021 Q3	–	Sell	-358	Closed	-$124K	–	287
2021 Q2	$124K	Sell	358 -35	-9%	-$10.6K	0.03%	137
2021 Q1	$110K	Sell	393 -51	-11%	-$13.8K	0.03%	138
2020 Q4	$109K	Sell	444 -32	-7%	-$8.26K	0.03%	128
2020 Q3	$135K	Hold	476	–	–	0.05%	125
2020 Q2	$127K	Sell	476 -758	-61%	-$228K	0.05%	124
2020 Q1	$390K	Buy	1,234 +728	+144%	+$221K	0.17%	86
2019 Q4	$150K	Sell	506 -10,818	-96%	-$3M	0.06%	114
2019 Q3	$2.64M	Buy	11,324 +409	+4%	+$95.2K	1%	42
2019 Q2	$2.55M	Buy	10,915 +701	+7%	+$162K	0.95%	45
2019 Q1	$2.41M	Buy	10,214 +1,982	+24%	+$624K	0.94%	47
2018 Q4	$2.48M	Sell	8,232 -635	-7%	-$203K	1.16%	28
2018 Q3	$3.13M	Buy	8,867 +1,081	+14%	+$372K	1.23%	29
2018 Q2	$2.26M	Buy	7,786 +566	+8%	+$159K	0.94%	42
2018 Q1	$1.98M	Buy	7,220 +2,590	+56%	+$804K	0.88%	46
2017 Q4	$1.48M	Buy	4,630 +87	+2%	+$27.9K	0.66%	62
2017 Q3	$1.42M	Buy	4,543 +534	+13%	+$158K	0.66%	60
2017 Q2	$1.09M	Sell	4,009 -412	-9%	-$109K	0.52%	70
2017 Q1	$1.21M	Buy	+4,421	New	+$1.25M	0.61%	59
2015 Q3	–	Sell	-285	Closed	-$115K	–	129
2015 Q2	$115K	Buy	+285	New	+$114K	0.05%	177
2014 Q3	–	Sell	-10,832	Closed	-$3.42M	–	161
2014 Q2	$3.42M	Buy	10,832 +597	+6%	+$180K	1.56%	13
2014 Q1	$3.13M	Buy	10,235 +180	+2%	+$57.1K	1.46%	13
2013 Q4	$2.81M	Buy	10,055 +375	+4%	+$97K	1.34%	17
2013 Q3	$2.33M	Buy	9,680 +10	+0.1%	+$2.24K	1.14%	21
2013 Q2	$2.08M	Buy	+9,670	New	+$2.07M	1.13%	23

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IMA Advisory Services's BIIB Position: Q2 2026 in Review

IMA Advisory Services increased its Biogen (BIIB) stake by 167% in Q2 2026, buying an estimated $2.87K and bringing the position to 24 shares worth $5.18K. The position accounts for ﹤0.01% of the portfolio, ranked #900.

IMA Advisory Services first reported a position in BIIB in Q2 2013 and has held it in 26 quarters since. The position peaked at $3.42M in Q2 2014. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

IMA Advisory Services held 24 shares of Biogen worth $5.18K as of Q2 2026.
IMA Advisory Services bought 15 Biogen shares in Q2 2026, an estimated $2.87K.
Biogen made up ﹤0.01% of IMA Advisory Services's portfolio in Q2 2026, its #900 holding.
IMA Advisory Services first reported a position in Biogen in Q2 2013 and has held it in 26 quarters since.
IMA Advisory Services's Biogen position peaked at $3.42M in Q2 2014.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.